BICO Group AB (publ) (OTCMKTS:CLLKF) Trading Down 16.6% – Should You Sell?

Shares of BICO Group AB (publ) (OTCMKTS:CLLKF) fell 16.6% on Tuesday . The company traded as low as C$1.90 and last traded at C$1.90. 3,400 shares changed hands during mid-day trading, an increase of 142% from the average session volume of 1,406 shares. The stock had previously closed at C$2.28.

BICO Group AB (publ) Trading Down 16.6%

The stock’s fifty day moving average is C$2.16 and its two-hundred day moving average is C$2.11.

About BICO Group AB (publ)

BICO Group AB (publ), formerly known as CELLINK AB, is a biotechnology company specializing in the development and commercialization of tools and solutions for life science research. The company’s core offerings include advanced 3D bioprinters, proprietary bioinks, microfluidic devices and cell analytics instruments. These technologies are designed to accelerate drug discovery, tissue engineering and personalized medicine by enabling researchers to create and analyze complex biological models in vitro.

In addition to its flagship bioprinting platforms, BICO provides a broad portfolio of consumables and software that support end-to-end workflows for cell culture and bioprocessing.